Biblio
“Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.”, J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
, “Weight Loss and Alzheimer's Disease in Down Syndrome.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1215-1227, 2022.
, “Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.”, J Alzheimers Dis, vol. 79, no. 2, pp. 671-681, 2021.
, “Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”, J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
, “Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.”, J Alzheimers Dis, vol. 56, no. 2, pp. 459-470, 2017.
, “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
, “A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 2, pp. 731-45, 2016.
,